If Washington Wants to Lower Prescription Drug Costs, It Should Get Out of Its Own Way
The Inflation Reduction Act’s Medicare drug price negotiation means fewer new treatments, Writesman argues. Congress needs to repeal it and pursue competition, transparency, and accountability instead.
